These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33385279)

  • 1. TransPrEP: Results from the Pilot Study of a Social Network-Based Intervention to Support PrEP Adherence Among Transgender Women in Lima, Peru.
    Clark J; Reisner S; Perez-Brumer A; Huerta L; Sanchez H; Moriarty K; Luque MM; Okochi H; Salazar X; Mimiaga M; Sanchez J; Gandhi M; Mayer KH; Lama JR
    AIDS Behav; 2021 Jun; 25(6):1873-1883. PubMed ID: 33385279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study.
    Veloso VG; Cáceres CF; Hoagland B; Moreira RI; Vega-Ramírez H; Konda KA; Leite IC; Bautista-Arredondo S; Vinícius de Lacerda M; Valdez Madruga J; Farias A; Lima JN; Zonta R; Lauria L; Tamayo CVO; Flores HJS; Santa Cruz YMC; Aguayo RMM; Cunha M; Moreira J; Makkeda AR; Díaz S; Guanira JV; Vermandere H; Benedetti M; Ingold HL; Pimenta MC; Torres TS; Grinsztejn B;
    Lancet HIV; 2023 Feb; 10(2):e84-e96. PubMed ID: 36565708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Social Networks Play a Complex Role in HIV Prevention Knowledge, Attitudes, Practices, and the Uptake of PrEP Through Transgender Women Communities Centered Around Three "Casas Trans" in Lima, Peru: A Qualitative Study.
    Temelkovska T; Moriarty K; Huerta L; Perez-Brumer A; Segura E; Passaro RC; Lake JE; Clark J; Blair C
    J Int Assoc Provid AIDS Care; 2023; 22():23259582231196705. PubMed ID: 37753609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial.
    Songtaweesin WN; Kawichai S; Phanuphak N; Cressey TR; Wongharn P; Saisaengjan C; Chinbunchorn T; Janyam S; Linjongrat D; Puthanakit T;
    J Int AIDS Soc; 2020 Sep; 23 Suppl 5(Suppl 5):e25564. PubMed ID: 32869511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study.
    Konda KA; Torres TS; Mariño G; Ramos A; Moreira RI; Leite IC; Cunha M; Jalil EM; Hoagland B; Guanira JV; Benedetti M; Pimenta C; Vermandere H; Bautista-Arredondo S; Vega-Ramirez H; Veloso VG; Caceres CF; Grinsztejn B;
    J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25974. PubMed ID: 36225148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PrEP Use and Adherence among Transgender Persons in Chicago, IL (SHIPP Study, 2014-2018, USA).
    Townes A; Pyra M; Smith DK; Babu AS; Williams T; Wiener J; Henny KD; Schneider J
    AIDS Behav; 2023 Mar; 27(3):901-908. PubMed ID: 36094640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Embedding a Linkage to Preexposure Prophylaxis Care Intervention in Social Network Strategy and Partner Notification Services: Results From a Pilot Randomized Controlled Trial.
    Teixeira da Silva D; Bouris A; Ramachandran A; Blocker O; Davis B; Harris J; Pyra M; Rusie LK; Brewer R; Pagkas-Bather J; Hotton A; Ridgway JP; McNulty M; Bhatia R; Schneider JA
    J Acquir Immune Defic Syndr; 2021 Feb; 86(2):191-199. PubMed ID: 33109935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
    Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM;
    Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project.
    Hoagland B; Moreira RI; De Boni RB; Kallas EG; Madruga JV; Vasconcelos R; Goulart S; Torres TS; Marins LMS; Anderson PL; Luz PM; Costa Leite ID; Liu AY; Veloso VG; Grinsztejn B;
    J Int AIDS Soc; 2017 Apr; 20(1):21472. PubMed ID: 28418232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Mobile Phone App to Support Adherence to Daily HIV Pre-exposure Prophylaxis Engagement Among Young Men Who Have Sex With Men and Transgender Women Aged 15 to 19 Years in Thailand: Pilot Randomized Controlled Trial.
    Kawichai S; Songtaweesin WN; Wongharn P; Phanuphak N; Cressey TR; Moonwong J; Vasinonta A; Saisaengjan C; Chinbunchorn T; Puthanakit T
    JMIR Mhealth Uhealth; 2022 Apr; 10(4):e25561. PubMed ID: 35451976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social Support Networks Among Young Men and Transgender Women of Color Receiving HIV Pre-Exposure Prophylaxis.
    Wood S; Dowshen N; Bauermeister JA; Lalley-Chareczko L; Franklin J; Petsis D; Swyryn M; Barnett K; Weissman GE; Koenig HC; Gross R
    J Adolesc Health; 2020 Mar; 66(3):268-274. PubMed ID: 31672523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing PrEP uptake and adherence among MSM and TW sex workers in Lima, Perú: what and whom do different patients trust?
    Longino A; Montano MA; Sanchez H; Bayer A; Sanchez J; Tossas-Milligan K; Duerr A; Molina Y
    AIDS Care; 2020 Feb; 32(2):255-260. PubMed ID: 31242753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers and Facilitators of PrEP Adherence for Young Men and Transgender Women of Color.
    Wood S; Gross R; Shea JA; Bauermeister JA; Franklin J; Petsis D; Swyryn M; Lalley-Chareczko L; Koenig HC; Dowshen N
    AIDS Behav; 2019 Oct; 23(10):2719-2729. PubMed ID: 30993479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to Oral Pre-Exposure Prophylaxis Intervention by Transgender Women: A Systematic Review.
    Moncayo JE; Pérez-Arizabaleta MDM; Villegas-Trujillo LM; Rodríguez-Ortiz A
    AIDS Educ Prev; 2023 Oct; 35(5):362-375. PubMed ID: 37843906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Disclosure of PrEP Nonadherence and HIV-Risk Behaviors Associated With Poor HIV PrEP Adherence in the HPTN 067/ADAPT Study.
    Ojeda VD; Amico KR; Hughes JP; Wilson E; Li M; Holtz TH; Chitwarakorn A; Grant RM; Dye BJ; Bekker LG; Mannheimer S; Marzinke M; Hendrix CW
    J Acquir Immune Defic Syndr; 2019 Sep; 82(1):34-40. PubMed ID: 31169769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating HIV pre-exposure prophylaxis and harm reduction among men who have sex with men and transgender women to address intersecting harms associated with stimulant use: a modelling study.
    Bórquez A; Rich K; Farrell M; Degenhardt L; McKetin R; Tran LT; Cepeda J; Silva-Santisteban A; Konda K; Cáceres CF; Kelly S; Altice FL; Martin NK
    J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25495. PubMed ID: 32562365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The wisdom of mistrust: qualitative insights from transgender women who participated in PrEP research in Lima, Peru.
    Perez-Brumer A; Naz-McLean S; Huerta L; Salazar X; Lama JR; Sanchez J; Silva-Santisteban A; Reisner SL; Mayer KH; Clark JL
    J Int AIDS Soc; 2021 Sep; 24(9):e25769. PubMed ID: 34569152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention-effective adherence trajectories among transgender women indicated for PrEP in the United States: a prospective cohort study.
    Cooney EE; Reisner SL; Saleem HT; Althoff KN; Beckham SW; Radix A; Cannon CM; Schneider JS; Haw JS; Rodriguez AE; Wawrzyniak AJ; Poteat TC; Mayer KH; Beyrer C; Wirtz AL;
    Ann Epidemiol; 2022 Jun; 70():23-31. PubMed ID: 35398255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief Report: Transgender Women and Preexposure Prophylaxis Care: High Preexposure Prophylaxis Adherence in a Real-World Health Care Setting in New York City.
    Starbuck L; Golub SA; Klein A; Harris AB; Guerra A; Rincon C; Radix AE
    J Acquir Immune Defic Syndr; 2022 May; 90(1):15-19. PubMed ID: 35013087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.